Rapid Micro Biosystems (RPID) Cash from Investing Activities (2020 - 2026)

Rapid Micro Biosystems has disclosed Cash from Investing Activities across 7 years of filings, most recently posting $8.6 million for Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at $8.6 million, down 19.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.2 million (down 63.8% YoY), and the FY2025 annual result was $14.3 million, down 60.91% from the prior year.
• Cash from Investing Activities came in at $8.6 million for Q1 2026 at Rapid Micro Biosystems, up from $3.9 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $24.8 million in Q2 2024 to a low of -$99.5 million in Q1 2022.
• The 5-year median for Cash from Investing Activities is $8.6 million (2026), against an average of $486235.3.
• Across the five-year window, Cash from Investing Activities sank 1846.41% in 2022 and jumped 508.63% in 2023, its largest moves.
• Rapid Micro Biosystems' Cash from Investing Activities stood at $12.8 million in 2022, then slipped by 21.81% to $10.0 million in 2023, then plunged by 51.41% to $4.9 million in 2024, then dropped by 20.07% to $3.9 million in 2025, then jumped by 121.15% to $8.6 million in 2026.
• The last three Cash from Investing Activities figures came in at $8.6 million (Q1 2026), $3.9 million (Q4 2025), and -$9.6 million (Q3 2025), per Business Quant data.